יומן אאוטלוק צור קשר
מרצים מוזמנים
  • Cathy Barr, Ph.D.
    Cathy Barr, Ph.D.

    Senior Scientist Hospital for Sick Children, Senior Scientist Toronto Western Research Institute, University Health Network, and Professor in the Department of Psychiatry at The University of Toronto
    Dr. Barr completed her Ph.D. in molecular biology at the University of Texas, Graduate School of Biomedical Sciences (M.D. Anderson Hospital) in Houston, Texas.  She then pursued her postdoctoral training in the genetics of complex behaviors at Yale University and subsequently at the Hospital for Sick Children in Toronto.  
    Dr. Barr’s research is focused on the study of childhood-onset psychiatric and cognitive disorders and functional studies of associated genes.

  • Joseph Biederman, MD
    Joseph Biederman, MD

    Prof. Biederman is Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders at the Massachusetts General Hospital, and Professor of Psychiatry at the Harvard Medical School.  Prof. Biederman is Board Certified in General and Child Psychiatry.

    Prof. Biederman has been a mentor to more than 15 junior investigators in the field.  He is on the editorial board of multiple journals, a reviewer for many Psychiatric journals, and has served as a grant reviewer in the Child Psychopathology and Treatment Review Committee of the NIMH.  

  • Edward (Ned) Hallowell
    Edward (Ned) Hallowell
    Edward (Ned) Hallowell, M.D., a child and adult psychiatrist, is a NY Times bestselling author, world-renowned speaker and leading authority in the field of ADHD. He is a graduate of Harvard College and Tulane Medical School, and the founder of The Hallowell Centers in Sudbury, Massachusetts and New York City. He was a member of the Harvard Medical School faculty from 1983 until he retired from academics in 2004 to devote his full professional attention to his clinical practice, lectures, and the writing of books.  He has authored eighteen books on various psychological topics, including attention deficit disorder, the power of the human connection, the childhood roots of happiness in life, methods of forgiving others, dealing with worry and managing excessive busyness.

    Dr. Hallowell is a highly recognized speaker around the world and has presented to thousands on topics such as ADD, strategies on handling your fast-paced life, the Childhood Roots of Adult Happiness and other pertinent family and health issues. His books have been sold over 2 million copies around the world.
  • James L. Kennedy, M.D., FRCP(C), FRSC
    James L. Kennedy, M.D., FRCP(C), FRSC

    Director, Neuroscience Research, CAMH
    Head of Neurogenetics Section, CAMH
    Head, Tanenbaum Centre for Pharmacogenetics
    Co-Director, Division of Brain and Therapeutics, Dept. of Psychiatry, and
    Professor, Department of Psychiatry and Institute of Medical Science,
    University of Toronto
    Fellow, Royal Society of Canada

    Dr. Kennedy has training in three major areas: neuroscience, clinical psychiatry, and molecular genetics. His main research interest over the past 20 years has been the identification of susceptibility genes for psychiatric disorders. His discoveries include: 1) the role of the DRD4 gene in ADHD, 2) the DRD3 gene predicting risk for Tardive Dyskinesia, 3) the 5HTTLPR genetic marker predicts risk for antidepressant induced mania. A major current project led by Dr. Kennedy is examining a large sample (N=20,000) of patients to determine the usefulness and cost-benefit of genetic testing applied to choice and dosage of psychiatric medications in clinical care. He has published pioneering findings relating gene variants in the dopamine, serotonin, and neurodevelopment systems to psychiatric disorders, neuroimaging (PET and MRI) and to treatment response. Dr. Kennedy has published more than 600 scientific articles with over 20,000 citations, and he is an active lecturer at numerous international conferences.

  • J.J. Sandra Kooij, MD, PhD
    J.J. Sandra Kooij, MD, PhD

    PsyQ
    Psycho-medical programs
    Program and Expertise Center Adult ADHD
    The Hague, The Netherlands

    Sandra Kooij started as a psychiatrist in 1995 with the development of diagnostic assessment, treatment and research in the field of adult ADHD in the Netherlands. In 2006 she received her PhD on a thesis entitled ‘ADHD in adults. Clinical studies on Assessment and Treatment’. She is involved in research, treating patients, training professionals, informing the public, publishing books, articles, and websites.

  • Jeffrey H. Newcorn, MD
    Jeffrey H. Newcorn, MD

    Associate Professor of Psychiatry and Pediatrics
    Director, Division of ADHD and Learning Disorders
    Icahn School of Medicine at Mount Sinai
    Director, Pediatric Psychopharmacology
    Mount Sinai Health System
    New York, New York

    Dr. Jeffrey Newcorn is an internationally recognized clinician-researcher who directs an active clinical trials program and has studied many of the newer medication treatments for ADHD. A steering committee member of the NIMH-funded multicenter study “Multimodal Treatment of Children with ADHD (MTA)”, he is the principal investigator on several NIMH-funded and industry-funded grants that examine the clinical presentation and neurobiological basis of ADHD and its treatment. He is a nationally recognized educator and an editorial board member of several leading child psychiatry and psychology journals, and has published over 250 peer-reviewed articles and book chapters on ADHD and related subjects.